# Ligand Pharmaceuticals Inc. (LGND)

> Ligand Pharmaceuticals Inc. (LGND) trades at $286.85 (-0.03%) as of 7:30:06 PM EST on Nov 20, 2026, -6.81% over the past month. Market cap is $5.74B, with 10.5 days to cover in short interest.

Canonical: https://massive.com/quote/lgnd
Data as of: 2026-11-21T00:30:06.047Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$286.85** -0.09 (-0.03%)
As of 7:30:06 PM EST on Nov 20, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Ligand Pharmaceuticals Inc. (LGND) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.03% |
| 1W | -7.11% |
| 1M | -6.81% |
| YTD | +51.72% |
| 1Y | +38.65% |
| 52-wk range | $175.89 – $326.63 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for LGND: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $282.36 – $291.36 |
| Open | $285.21 |
| Prev close | $286.94 |
| Volume | 259.79K |
| Market cap | $5.74B |
| Shares out | 20M |

## Valuation and profitability ratios

Valuation and profitability ratios for Ligand Pharmaceuticals Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 111.50 |
| P/S | 22.61 |
| P/B | 5.97 |
| P/FCF | 63.31 |
| ROE | 5.3% |
| ROA | 2.3% |
| Debt/Equity | 1.17 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[Ligand Pharmaceuticals Inc. (LGND) insider trading](https://massive.com/quote/lgnd/insider-trading.md): open-market Form 4 buys and sells by Ligand Pharmaceuticals Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Ligand Pharmaceuticals Inc. has disclosed to the SEC on Form 8-K.

- Oct 29, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On October 29, 2026, Ligand Pharmaceuticals Incorporated (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2026.”
- Jul 14, 2026 · [Merger completion](https://massive.com/quote/sec-filings/8-k/mergers.md)
  “On July 14, 2026, the Company consummated the previously announced Merger with HoldCo in accordance with the terms of the Merger Agreement. Pursuant to the Merger Agreement, XOMA Royalty effected the Holding Company Reorganization (as defined below) prior to giving effect to the Merger.”
- Jun 25, 2026 · Warrant or conversion
  “On June 22, 2026, concurrently with the pricing of the Notes, and June 23, 2026, concurrently with the initial purchasers' exercise of the option to purchase additional Notes, the Company entered into privately negotiated warrant transactions to sell to the Counterparties warrants (the "Warrants") to acquire, collectively, subject to customary anti-dilution adjustments, up to the same number of shares of Common Stock covered by the Purchased Options at an initial strike price of $524.3400 per share.”
- Jun 22, 2026 · Private placement
  “the Company issued a press release announcing the proposed offering of $550 million aggregate principal amount of convertible senior notes due 2031 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.”
- Jun 9, 2026 · Annual meeting results
  “The 2026 Annual Meeting of the Stockholders of Ligand Pharmaceuticals Incorporated (the "Company") was held on June 5, 2026 (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders approved an amendment and restatement of the Company's 2002 Stock Incentive Plan.”

## Dividend history and stock splits

Ligand Pharmaceuticals Inc.'s recent dividend payments and stock splits.

### Dividends

- $0.08 · ex-div Jul 2, 2010
- $2.50 · ex-div Apr 3, 2007

### Splits

- 1-for-6 · Nov 19, 2010

## Similar companies

Public companies in a similar business to Ligand Pharmaceuticals Inc..

- [ANIP](https://massive.com/quote/anip.md) ANI Pharmaceuticals, Inc. (-0.84%)
- [ADMA](https://massive.com/quote/adma.md) ADMA Biologics, Inc. (-1.27%)

Daily change in the latest session, 15-minute delayed.

## LGND short interest

How heavily LGND is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 10.5 |
| Short interest | 2.46M |
| Avg volume | 234.09K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## LGND news

The latest news and headlines about Ligand Pharmaceuticals Inc. (LGND).

- [Ligand to Participate in September Investor Conferences](https://www.globenewswire.com/news-release/2026/08/26/3351186/0/en/ligand-to-participate-in-september-investor-conferences.html) · GlobeNewswire Inc. · Aug 26, 2026 · neutral sentiment
- [3 Overlooked Stocks Positioned for the Next Market Rotation](https://www.investing.com/analysis/3-overlooked-stocks-positioned-for-the-next-market-rotation-200683831) · Investing.com · Jul 13, 2026 · positive sentiment
- [CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?](https://www.fool.com/coverage/better-buy/2026/07/06/crispr-therapeutics-ag-vs-viking-therapeutics-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001) · The Motley Fool · Jul 6, 2026 · positive sentiment
- [XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date](https://www.benzinga.com/pressreleases/26/06/g53179293/xoma-royalty-corporation-declares-quarterly-preferred-stock-dividend-and-announces-redemption-of-i?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Jun 12, 2026 · neutral sentiment
- [Ligand Announces 2026 Investor Day in New York City](https://www.globenewswire.com/news-release/2026/06/10/3309572/0/en/Ligand-Announces-2026-Investor-Day-in-New-York-City.html) · GlobeNewswire Inc. · Jun 10, 2026 · positive sentiment

## About Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 47 |
| Listed | Nov 25, 1994 |

[Company website](https://www.ligand.com)

## FAQ

### What is the Ligand Pharmaceuticals Inc. (LGND) stock price today?

Ligand Pharmaceuticals Inc. (LGND) is trading at $286.85 (-0.03% on the day) as of 7:30:06 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Ligand Pharmaceuticals Inc.?

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies.

### What is the short interest in LGND?

As of Oct 30, 2026, LGND has 2.46M shares short and 10.5 days to cover.

### Does Ligand Pharmaceuticals Inc. (LGND) pay a dividend?

Yes. Ligand Pharmaceuticals Inc. (LGND)'s most recent dividend was $0.08 per share, with an ex-dividend date of Jul 2, 2010. Full LGND dividend history is available from the Massive API.

### What exchange is LGND listed on?

Ligand Pharmaceuticals Inc. (LGND) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time LGND quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=LGND`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Ligand Pharmaceuticals Inc. (LGND) insider trading](https://massive.com/quote/lgnd/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
